Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Innovative EyewearLUCY -0.84%57 EV-to-EBITDA is -0.25 as of Aug. 20, 2026. GuruFocus rates LUCY with a GF Score™ of 57/100 and a GF Value™ of $1.50 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 515 Medical Devices & Instruments companies, Innovative Eyewear ranks worse than 194174.56% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Innovative Eyewear's enterprise value is $2.07 Mil.
Innovative Eyewear's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was $-8.38 Mil. Therefore, Innovative Eyewear's EV-to-EBITDA for today is -0.25.
The historical rank and industry rank for Innovative Eyewear's EV-to-EBITDA or its related term are showing as below:
LUCY'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -6.47 Med: -0.14 Max: 0.35
Current: -0.25
During the past 7 years, the highest EV-to-EBITDA of Innovative Eyewear was 0.35. The lowest was -6.47. And the median was -0.14.
LUCY's EV-to-EBITDA is ranked worse than 100% of 515
companies
in the Medical Devices & Instruments industry
Industry Median: 15.16
vs LUCY: -0.25
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Innovative Eyewear's PE Ratio (TTM) for today is calculated as:
Innovative Eyewear's share price for today is $0.6753.
Innovative Eyewear's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.290.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Innovative Eyewear's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LUCY vs NXGL, MHUAF, RSCF: EV-to-EBITDA Comparison
For the Medical Instruments & Supplies subindustry, Innovative Eyewear's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Innovative Eyewear EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Innovative Eyewear's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Innovative Eyewear's EV-to-EBITDA falls into.
Innovative Eyewear's current Enterprise Value is $2.07 Mil.
Innovative Eyewear's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.38 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Innovative Eyewear (LUCY) has a EV-to-EBITDA of -0.25 as of Aug. 20, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Innovative Eyewear. According to the industry distribution chart, Innovative Eyewear ranks #999999 out of 515 companies in the Medical Devices & Instruments industry.
Is Innovative Eyewear's EV-to-EBITDA too high?
Innovative Eyewear's current EV-to-EBITDA is -0.25. Based on the distribution chart, Innovative Eyewear ranks #999999 out of 515 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Innovative Eyewear has a GF Score™ of 57/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Innovative Eyewear's EV-to-EBITDA compare to NXGL and MHUAF?
According to the Medical Devices & Instruments industry distribution chart, Innovative Eyewear ranks #999999 out of 515 companies for EV-to-EBITDA. This places Innovative Eyewear in the lower half of its industry. The industry median EV-to-EBITDA is 15.16. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 15.16, based on 515 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Innovative Eyewear. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 15.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Innovative Eyewear's current EV-to-EBITDA is -0.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovative Eyewear stock overvalued right now?
Based on GuruFocus' analysis, Innovative Eyewear (LUCY) is currently considered Possible Value Trap. The stock's GF Value™ is $1.50, compared to a current price of $0.68 — trading 55% below its estimated fair value. The current EV-to-EBITDA is -0.25. Innovative Eyewear's overall GF Score™ is 57/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Innovative Eyewear (LUCY), the current EV-to-EBITDA is -0.25 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Innovative Eyewear (LUCY) Overvalued in 2026?
Based on GuruFocus' analysis, Innovative Eyewear stock appears to be undervalued.
The current stock price of $0.68 is trading 55% below its estimated GF Value™ of $1.50.
GuruFocus considers Innovative Eyewear to be Possible Value Trap.
Key valuation signals for LUCY:
EV-to-EBITDA: -0.25
GF Value™: $1.50 vs. price of $0.68 (55% below fair value)
No single metric tells the full story. See the LUCY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok. The firm derive substantially all of its revenue from the sale of smart glasses and custom lenses.
57GF Score
Get the complete analysis for LUCY
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LUCY has been successfully added to your 
